These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30526722)

  • 21. Association of Val66Met polymorphism at brain derived neurotrophic factor gene with depression among Chinese adolescents after Wenchuan earthquake: An 18months longitudinal study.
    Fan M; Li RH; Hu MS; Xiao LY; Zhou XD; Ran MS; Fang DZ
    Physiol Behav; 2017 Oct; 179():16-22. PubMed ID: 28527683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive roles of brain-derived neurotrophic factor Val66Met polymorphism on antidepressant efficacy of different forms of prefrontal brain stimulation monotherapy: A randomized, double-blind, sham-controlled study.
    Cheng CM; Hong CJ; Lin HC; Chu PJ; Chen MH; Tu PC; Bai YM; Chang WH; Juan CH; Lin WC; Tsai SJ; Su TP; Li CT
    J Affect Disord; 2022 Jan; 297():353-359. PubMed ID: 34715162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse.
    Grabe HJ; Schwahn C; Mahler J; Appel K; Schulz A; Spitzer C; Fenske K; Barnow S; Freyberger HJ; Teumer A; Petersmann A; Biffar R; Rosskopf D; John U; Völzke H
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):264-70. PubMed ID: 21996278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder.
    Wang J; Zhang F; Zhu W; Liu Y; Zhou Z
    Acta Neuropsychiatr; 2015 Dec; 27(6):327-35. PubMed ID: 26503495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression.
    Nikolac Perkovic M; Gredicak M; Sagud M; Nedic Erjavec G; Uzun S; Pivac N
    Expert Rev Mol Diagn; 2023 Apr; 23(4):283-296. PubMed ID: 37038358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between dietary quality, serum brain-derived neurotrophic factor (BDNF) level, and the Val66met polymorphism in predicting depression.
    Froud A; Murphy J; Cribb L; Ng CH; Sarris J
    Nutr Neurosci; 2019 Jul; 22(7):513-521. PubMed ID: 29280414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.
    Niciu MJ; Iadarola ND; Banerjee D; Luckenbaugh DA; Park M; Lener M; Park L; Ionescu DF; Ballard ED; Brutsche NE; Akula N; McMahon FJ; Machado-Vieira R; Nugent AC; Zarate CA
    J Psychopharmacol; 2017 Dec; 31(12):1570-1577. PubMed ID: 29039254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population.
    Wang Z; Li Z; Chen J; Huang J; Yuan C; Hong W; Yu S; Fang Y
    Genes Brain Behav; 2012 Jul; 11(5):524-8. PubMed ID: 22548711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of dietary insulin index and dietary insulin load with brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in relation to cardiometabolic markers in Iranian diabetic patients: a cross-sectional study.
    Abaj F; Rafiee M; Koohdani F
    Br J Nutr; 2022 Sep; 128(5):785-792. PubMed ID: 34605382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between brain-derived neurotrophic factor Val66Met polymorphism and recent negative stressor in harm avoidance.
    Kim SJ; Cho SJ; Jang HM; Shin J; Park PW; Lee YJ; Cho IH; Choi JE; Lee HJ
    Neuropsychobiology; 2010; 61(1):19-26. PubMed ID: 19923862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia.
    Bonaccorso S; Sodhi M; Li J; Bobo WV; Chen Y; Tumuklu M; Theleritis C; Jayathilake K; Meltzer HY
    Bipolar Disord; 2015 Aug; 17(5):528-35. PubMed ID: 25874530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural neuroimaging correlates of allelic variation of the BDNF val66met polymorphism.
    Forde NJ; Ronan L; Suckling J; Scanlon C; Neary S; Holleran L; Leemans A; Tait R; Rua C; Fletcher PC; Jeurissen B; Dodds CM; Miller SR; Bullmore ET; McDonald C; Nathan PJ; Cannon DM
    Neuroimage; 2014 Apr; 90():280-9. PubMed ID: 24384148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological correlates of the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism.
    Roy N; Barry RJ; Fernandez FE; Lim CK; Al-Dabbas MA; Karamacoska D; Broyd SJ; Solowij N; Chiu CL; Steiner GZ
    Sci Rep; 2020 Oct; 10(1):17915. PubMed ID: 33087740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Serum Biomarker Levels and BDNF Gene Polymorphism with Response to Selective Serotonin Reuptake Inhibitors in Indian Patients with Major Depressive Disorder.
    Ramesh V; Venkatesan V; Chellathai D; Silamban S
    Neuropsychobiology; 2021; 80(3):201-213. PubMed ID: 32731218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response.
    Tsai SJ; Cheng CY; Yu YW; Chen TJ; Hong CJ
    Am J Med Genet B Neuropsychiatr Genet; 2003 Nov; 123B(1):19-22. PubMed ID: 14582140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression.
    Musil R; Zill P; Seemüller F; Bondy B; Obermeier M; Spellmann I; Bender W; Adli M; Heuser I; Zeiler J; Gaebel W; Maier W; Rietschel M; Rujescu D; Schennach R; Möller HJ; Riedel M
    Eur Arch Psychiatry Clin Neurosci; 2013 Aug; 263(5):405-12. PubMed ID: 22965830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
    Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
    Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Analysis of the Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Gender with Efficacy of Antidepressants in the Chinese Han Population with Generalized Anxiety Disorder.
    Lin M; Zhu J; Yuan Y; Ren L; Qian M; Shen Z; Shao Y; Shen X
    Genet Test Mol Biomarkers; 2018 Mar; 22(3):199-206. PubMed ID: 29446659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide.
    Youssef MM; Underwood MD; Huang YY; Hsiung SC; Liu Y; Simpson NR; Bakalian MJ; Rosoklija GB; Dwork AJ; Arango V; Mann JJ
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):528-538. PubMed ID: 29432620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects.
    Zhou JX; Li HC; Bai XJ; Chang BC; Li CJ; Sun P; Chen LM
    Behav Brain Funct; 2013 Aug; 9():34. PubMed ID: 23968401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.